Investors with many years of experience in biotech know there's
something to the idea that the best time to prepare for war is during
peace (and vice versa). With the biotech sector heading for its second
straight year of strong returns, it's worth asking whether investors are
getting a little too cavalier about risk and whether investors in the
sector are getting set up for a sizable correction.
Please continue here:
Is Biotech Getting Too Frothy? Investor Sentiment Suggests Irrational Exuberance
No comments:
Post a Comment